QA: Albireo Pharma INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001322505_2018_Albireo_Pharma_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001322505, Albireo Pharma INC

  xvar xval
0 AssetsCurrent 55,011,000
1 IntangibleAssetsNetIncludingGoodwill 17,260,000
2 PropertyPlantAndEquipmentNet 178,000
3 remainder_Assets 775,000
4 LiabilitiesCurrent 7,929,000
5 LiabilitiesNoncurrent 42,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 15,303,772
9 ResearchAndDevelopmentExpense 12,215,252
10 remainder_Expenses -16,318,627
11 remainder_Revenues 11,187,482
12 remainder_NetIncome -1,180,675
13 remainder_ComprehensiveNetIncome 690,725
  yvar yval
0 Assets 73,224,000
1 Liabilities 7,971,000
2 Expenses 11,200,397
3 Revenues 11,187,482
4 StockholdersEquity 65,253,000
5 NetIncome -1,193,590
6 ComprehensiveNetIncome -848,228
7 BaseVar 52,727,140
8 EconomicCapitalRatiobeforeLimitedLiability 3.48
9 EconomicCapitalRatio 4.02

Edgar->Model Mapping

Feature Distribution

Change over Time